3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with beta-endorphin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coyne, KE; Farah, JM; Iyengar, S; Mick, SJ; Rao, TS | 1 |
Bagdy, G; Calogero, AE; Chrousos, GP; Gold, PW; Gomez, MT; Murphy, DL; Szemeredi, K | 1 |
2 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and beta-endorphin
Article | Year |
---|---|
N-methyl-D-aspartate treatment increases circulating adrenocorticotropin and luteinizing hormone in the rat.
Topics: Adrenocorticotropic Hormone; Animals; beta-Endorphin; Corticosterone; Dexamethasone; Kinetics; Luteinizing Hormone; Male; N-Methylaspartate; Piperazines; Pituitary Gland; Rats; Receptors, N-Methyl-D-Aspartate | 1991 |
Beta-endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Arginine Vasopressin; beta-Endorphin; Cells, Cultured; Corticotropin-Releasing Hormone; Dexamethasone; Male; Piperazines; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains; Serotonin; Tetrahydronaphthalenes; Vasopressins | 1990 |